
Accendra Health, Inc.
ACHNYSEHealthcareMedical - Distribution
Previous close
$1.20
−$0.11 · -8.40%
ACH company overview
Historical prices · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
82
Deep Value
Momentum
48
Neutral
Sentiment
59
Mixed
Risk resilience
26
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAccendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Edward A. Pesicka
- Listed since
- Mar 17, 1980
- Employees
- 6,500
Market position
Day range
Current $1.20
52-week range
Current $1.20
- Open
- $1.28
- Previous close
- $1.31
- Volume
- 1.62M
- 1.54× average
- Average volume
- 1.05M
- Average daily volume
- Market cap
- 91.9M USD
- Beta
- 1.61
- Market reference 1
- 50-day average
- $2.8618
- -58.07% below average
- 200-day average
- $2.7394
- -56.19% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.17B USD
- P/E (TTM)
- -0.31×
- P/B (TTM)
- -0.17×
- P/S (TTM)
- 0.03×
- EV / EBITDA
- 9.86×
- Earnings yield
- -511.19%
- Free cash flow yield
- -140.78%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 44.83%
- Operating margin
- 3.62%
- Net margin
- -11.41%
- Return on equity
- 238.76%
- Return on assets
- -44.89%
- Return on invested capital
- 12.33%
Financial health
- Debt / equity
- -3.23×
- Current ratio
- 0.58×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.76B USD | 10.7B USD | 10.33B USD | 9.96B USD | 9.79B USD |
| Cost of goods sold | 1.47B USD | 8.48B USD | 8.21B USD | 8.13B USD | 8.27B USD |
| Gross profit | 1.29B USD | 2.22B USD | 2.13B USD | 1.83B USD | 1.51B USD |
| Research and development | — | — | — | — | 12.1M USD |
| Selling, general, and administrative | 1.07B USD | 1.91B USD | 1.81B USD | 1.55B USD | 1.08B USD |
| Operating expenses | 1.07B USD | 2.43B USD | 2.02B USD | 1.68B USD | 1.14B USD |
| Interest expense | 107.18M USD | 143.8M USD | 157.92M USD | 128.89M USD | 48.09M USD |
| Depreciation and amortization | 214.52M USD | 264.78M USD | 287.38M USD | 228.67M USD | 90.62M USD |
| Operating income | 221.74M USD | −207.77M USD | 104.51M USD | 142.91M USD | 368.47M USD |
| Net income | −1.1B USD | −362.69M USD | −41.3M USD | 22.39M USD | 221.59M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 73%
- 8 beats, 3 misses, 0 met estimates
- Average EPS surprise
- -4.25%
- 11 comparable reports
- Latest EPS result
- -0.19
- Estimate -0.08 · Miss by 126.65%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
ACH news
ACH peers
ETFs holding ACH
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI6.75M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Extended Market ETFVXF2.57M0.00%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 ETFIWM2.49M0.00%81.62B USD0.19%$299.96+0.77%
Schwab Fundamental U.S. Small Company Index ETFFNDA2.28M0.02%9.26B USD0.25%$37.73+0.75%
Vanguard U.S. Value Factor ETFVFVA1.46M0.17%912.5M USD0.13%$162.26+1.08%
Vanguard Russell 2000 ETFVTWO1.25M0.01%17.4B USD0.06%$121.25+0.74%
iShares Russell 2000 Value ETFIWN872.98K0.01%14.66B USD0.24%$224.81+0.45%
Vanguard Health Care ETFVHT575.69K0.00%20.9B USD0.09%$327.7+1.24%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 6.75M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 2.57M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 ETFIWM- Market value
- 2.49M
- Weight
- 0.00%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Schwab Fundamental U.S. Small Company Index ETFFNDA- Market value
- 2.28M
- Weight
- 0.02%
- AUM
- 9.26B USD
- Expense ratio
- 0.25%
- Price / 1D
- $37.73+0.75%
Vanguard U.S. Value Factor ETFVFVA- Market value
- 1.46M
- Weight
- 0.17%
- AUM
- 912.5M USD
- Expense ratio
- 0.13%
- Price / 1D
- $162.26+1.08%
Vanguard Russell 2000 ETFVTWO- Market value
- 1.25M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
iShares Russell 2000 Value ETFIWN- Market value
- 872.98K
- Weight
- 0.01%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Vanguard Health Care ETFVHT- Market value
- 575.69K
- Weight
- 0.00%
- AUM
- 20.9B USD
- Expense ratio
- 0.09%
- Price / 1D
- $327.7+1.24%
Continue in GoAI
Research ACHresearch.disclaimer











